Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu


Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.




Publications & Presentations

<< 2 3 4 5 6 7 8 > >>
    21. Dickson M C, Nguyen M M, Skrepnek G H. Medicaid Value-Based Contract (VBC) in the prevention of migraine [Legislative Report]. Oklahoma Health Care Authority. 2021

    22. Schwier N C, Cannedy J J, Skrepnek G H. Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. Advanced emergency nursing journal. 2020; 42 : 17-29

    23. Schwier N C, Cannedy J J, Skrepnek G H. Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. Advanced emergency nursing journal. 2020; 42 : 17-29

    24. Gentry C A, Nguyen P K, Thind S, Kurdgelashvili G, Skrepnek G H, Williams R J. Fidaxomicin versus Oral Vancomycin for Severe Clostridium difficile Infection. Clinical Microbiology and Infection . 2019; 25 : 987-993

    25. Pham T, Rathbun C, Keast S, Nesser N, Farmer K, Skrepnek G H. National estimates of case-mix, mortality, and economic outcomes amoung inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the U.S. Journal Evaluation Clinical Practice. 2019; 25 : 806-821

<< 2 3 4 5 6 7 8 > >>



Grants

<< 1 2 3 4 >>
    11. Improving the Health of Americans through Prevention and Management of Diabetes, Heart Disease, and Stroke. Non-federal. Start Date: 2019. End Date: 2020.

    12. Allergan (PI: Keast). Federal Non-NIH. Start Date: 2018. End Date: 2019.

    13. Otsuka (Skrepnek/Keast PI). Non-federal. Start Date: 2018. End Date: 2019.

    14. Research Fellowship. PhRMA. Start Date: 2017. End Date: 2018.

    15. Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. Misc Non-Federal. Start Date: 2017.

<< 1 2 3 4 >>



Awards and Honors

                                                                                            1. Academy of Managed Care Pharmacy Nexus 2022, National Harbor, MD, Oct. 11-14, 2022. Top Conference Poster (Student, Matthew C. Dickson). Date: 2022.  

                                                                                            2. Academy of Managed Care Pharmacy. Bronze Recognition. Date: 2015.  

                                                                                            3. International Symposium of the Diabetic Foot. Top Conference Podium. Date: 2015.  




Education


no results

Administrative Assignments

                                                

    1. Role: Director. Scope: Department. Date: 2019.

                                                

    2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.